Project Details
Projekt Print View

Harnessing the mitochondrial vulnerability of neurons from Huntington´s disease patients for uncovering novel therapeutic targets

Subject Area Molecular and Cellular Neurology and Neuropathology
Term from 2020 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 423776278
 
Final Report Year 2024

Final Report Abstract

In our project, we have demonstrated that the technology of iPSC reprogramming can be used to investigate the impact of HD on neurodevelopment. We have identified a novel target of intervention CHCHD2, which impacts neurodevelopment through a mitochondrial-related mechanism. Hence, mitochondrial dysfunction could represent a key mechanistic aspect in the early establishment of HD pathogenesis. We believe that our findings are important not only for the scientific community in the field of stem cells, HD, and mitochondria, but may also be worth sharing with the patient community and the general public. HD is a rare incurable disease and therefore it is important to increase awareness in the public. Affected patients and related families may be interested to hear about our scientific advances that have the potential to help establish new potential treatment options to some of the affected individuals.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung